About SciGenom
SciGenom is a company based in Kochi (India) founded in 2009 by Sam Santhosh. SciGenom has raised $364.03 thousand across 2 funding rounds from investors including Department of Biotechnology, Shreedharn Nair and Jlds Research AND Consultancy. The company has 12 employees. SciGenom operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Strateos and Beikang Medical, among others.
- Headquarter Kochi, India
- Employees 12
- Founders Sam Santhosh
- SectorsHealthcare
- Website scigenom.com
- Social LinkedIn
- Annual Revenue$688.87 K (USD)2as on Mar 31, 2024
- Net Profit$65.84 K (USD)111as on Mar 31, 2024
- EBITDA$136.49 K (USD)127as on Mar 31, 2024
- Total Equity Funding$364.03K (USD)
in 2 rounds
- InvestorsDepartment of Biotechnology
& 2 more
- Employee Count12
Associated legal entities of SciGenom
SciGenom is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2020) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Scigenom Lifesciences Private Limited CIN U24100TN2018PTC124916 | Strike Off | 27 Sep 2018 | Chennai, Tamil Nadu | – | – | 2 | View details |
| Scigenom Labs Private Limited CIN U73200KL2009PTC039290 | Active | 17 Apr 2009 | Ernakulam, Kerala | ₹5.7 Cr | 12 | 2 | View details |
Funding Insights of SciGenom
SciGenom has successfully raised a total of $364.03K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $364,032
- Total Rounds 2
- First Round $364,032
(Mar 2012)
- Investors Count 3
All 2 funding rounds of SciGenom with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | – | Grant | – | – | |
| Mar 2012 | $364,032 | Seed | $379,916 | Jlds Research AND Consultancy |
Last known valuation $379,916 (Mar 2012). 3 investors in total: 2 institutional and 1 angel.
Investors in SciGenom
SciGenom has secured backing from 3 investors, including institutional and angel investors. Prominent investors backing the company include Department of Biotechnology, Shreedharn Nair and Jlds Research AND Consultancy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotechnology research, guidelines, and funding by the Government of India. | 1986 | dbtindia.gov.in | Delhi, India | |
- | – | jldreserchandounsultancy.tcc.mode | - | |
SN Shreedharn Nair | - | – | unknown_aa2465fb13034e878 | - |
Investor details for SciGenom
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of SciGenom
The boards of the 2 registered companies of SciGenom currently have 2 directors; the longest-serving is Balamaniamma Madathinkal Raghavan Nair, appointed in 2018. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Balamaniamma Madathinkal Raghavan Nair DIN 02231058 | Director | 27 Sep 2018 | 8 yrs | Scigenom Lifesciences Private Limited, Scigenom Labs Private Limited |
| Sreedhar Santhosh DIN 00422809 | Director | 27 Sep 2018 | 8 yrs | Scigenom Lifesciences Private Limited, Scigenom Labs Private Limited |
People of SciGenom
1 people are tracked at SciGenom (1 in leadership); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Sam Santhosh | Founder, CEO & Chairman | Leadership |
Complete people profiles for SciGenom
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SciGenom
Figures of Scigenom Labs Private Limited, the primary company behind SciGenom, for FY 2024. Revenue was ₹5.70 Cr (+2% year on year). Net profit was ₹54.5 Lakh (10% margin). EBITDA was ₹1.13 Cr (20% margin). Revenue has grown at a compounded annual rate of +4% over three years and +9% over five years.
- ₹5.70 CrRevenue · FY 2024 · +2% YoY
- ₹54.5 LakhNet profit · 10% margin
- ₹1.13 CrEBITDA · 20% margin
- ₹49.6 LakhPaid-up capital
- 12Employees (provident fund records)
- +4%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Scigenom Labs Private Limited are on its company page.
Detailed financial statements for SciGenom
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of SciGenom
3 dated milestones of SciGenom across 6 years, from founding to its latest funding, stage changes and deals.
- Founded SciGenom is founded.
- Funding First funding round of $364K.
- Funding Latest funding round, Grant,.
Competitors of SciGenom
SciGenom operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Strateos and Beikang Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| sourcebioscience.com | 1903 | Nottingham, United Kingdom | – | 273 | Multiple genomic services are provided for analysis and diagnostics. | |
| strateos.com | 2019 | Menlo Park, United States | $72.6M | 147 | Provider of cloud based platform provides data driven information for biotech research | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| macrogen.com | 1997 | Seoul, South Korea | – | – | Next-generation sequencing and genomics services are provided globally. | |
| mgrc.com.my | 2004 | Kuala Lumpur, Malaysia | – | – | Genome sequencing, analysis, and genetic screening services are provided. | |
| enarabio.com | 2016 | Oxford, United Kingdom | $84.05M | 38 | T-cell interfaces for cancer therapeutics are developed. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| 20n.com | 2013 | San Francisco, United States | $2.22M | – | Computational tools are developed to engineer microbes for synthetic biology. |
Detailed competitors of SciGenom
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SciGenom
The website of SciGenom (scigenom.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 44.6% vs previous month
Websites whose visitors overlap most with SciGenom. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| xcelrisgenomics.com | 100% | – | – | View details | |
| igib.res.in | 94% | 26.2K | – | View details | |
| cofactorgenomics.com | 91% | 4.2K | #4,572,217 | View details | |
genoma.unsam.edu.ar | genoma.unsam.edu.ar | 90% | – | – | – |
genome.wustl.edu | genome.wustl.edu | 90% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for SciGenom
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Scigenom
Complete news archive for SciGenom
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to SciGenom
10 companies that operate in the same segment as SciGenom (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SciGenom
SciGenom was founded in 2009 and raised its 1st funding round 3 years after it was founded.
SciGenom is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.
Sam Santhosh is the current CEO of SciGenom. They have also founded this company.
SciGenom is a funded company, having raised a total of $364.03K across 2 funding rounds to date. The company's 1st funding round was a Seed of $364.03K, raised on Mar 2012.
SciGenom has 12 employees.
Annual revenue of SciGenom is $688.87K as on Mar 31, 2024.
SciGenom was founded in 2009 and is based in Kochi, India. Genome sequencing services, including next-generation and Sanger methods, are offered alongside bioinformatics tools for data analysis and laboratory information management. Additional operations encompass custom oligonucleotide synthesis, microbial identification, and cloning. Grants from DBT under SBIRI and BIPP have supported development of single-tube multigene oncodiagnostic tests compatible with NGS platforms, serving the life science and healthcare sectors.
SciGenom's top competitors include Novogene Corporation, Source BioScience and Genewiz.
SciGenom has 3 investors. Key investors include Department of Biotechnology, Shreedharn Nair, and Jlds Research AND Consultancy.
The valuation of SciGenom is $379.92K as of Mar 2012.
SciGenom is associated with 2 legal entities: Scigenom Lifesciences Private Limited, Scigenom Labs Private Limited.
The legal entities of SciGenom currently have 2 directors, including Balamaniamma Madathinkal Raghavan Nair, Sreedhar Santhosh.